Morgan Stanley’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Morgan Stanley’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-98,337	Closed	-$969K	–	8208
2022 Q1	$969K	Sell	98,337 -69,177	-41%	-$679K	﹤0.01%	5019
2021 Q4	$1.64M	Buy	167,514 +167,034	+34,799%	+$1.65M	﹤0.01%	4729
2021 Q3	$5K	Sell	480 -59,611	-99%	-$587K	﹤0.01%	7512
2021 Q2	$595K	Buy	60,091 +57,396	+2,130%	+$578K	﹤0.01%	5414
2021 Q1	$27K	Buy	+2,695	New	+$29.9K	﹤0.01%	6619

Other funds holding LUXA

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Wolfswood Holdings New York $2.84M AUM 30.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Morgan Stanley's LUXA Position: Q2 2022 in Review

Morgan Stanley sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q2 2022, closing a stake of 98,337 shares — an estimated $969K sold.

Morgan Stanley first reported a position in LUXA in Q1 2021 and held it in 5 quarters. The position peaked at $1.64M in Q4 2021. 71 funds tracked by Wall St. Rank hold LUXA as of Q2 2022.

Morgan Stanley reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Morgan Stanley sold 98,337 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q2 2022, an estimated $969K.
Morgan Stanley first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 5 quarters.
Morgan Stanley's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $1.64M in Q4 2021.
71 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.